Ipamorelin is a highly selective ghrelin receptor agonist that increases GH release with minimal effects on appetite, cortisol, or prolactin. It is favored in studies requiring a “clean” GH secretagogue profile.

Research Focus:

• Selective GH release
• Recovery and lean mass
• Anti-aging research

Sources:

Selective GHRP with minimal ACTH/cortisol (J Endocrinol Invest): https://link.springer.com/article/10.1007/BF03345217

Ghrelin receptor/secretagogues review (Endocrine Reviews): https://academic.oup.com/edrv/article/26/3/289/2355083

Clinical endocrine effects summary (JCEM): https://academic.oup.com/jcem/article/83/2/362/2864871

⚠️ Disclaimer: For research use only. Not intended for human consumption. This information is provided for educational purposes and has not been evaluated by the FDA.